Literature DB >> 33332000

Constituents of Cannabis Sativa.

Erin M Rock1, Linda A Parker2.   

Abstract

The Cannabis sativa plant has been used medicinally and recreationally for thousands of years, but recently only relatively some of its constituents have been identified. There are more than 550 chemical compounds in cannabis, with more than 100 phytocannabinoids being identified, including Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD). These phytocannabinoids work by binding to the cannabinoid receptors, as well as other receptor systems. Also within cannabis are the aromatic terpenes, more than 100 of which have been identified. Cannabis and its constituents have been indicated as therapeutic compounds in numerous medical conditions, such as pain, anxiety, epilepsy, nausea and vomiting, and post-traumatic stress disorder. This chapter provides an overview of some of the biological effects of a number of the cannabinoids and terpenes, as well as discussing their known mechanisms of action and evidence of potential therapeutic effects.

Entities:  

Keywords:  Cannabidiol; Cannabinoid receptors; Cannabis sativa; Phytocannabinoid; Terpene; Δ9-tetrahydrocannabinol

Year:  2021        PMID: 33332000     DOI: 10.1007/978-3-030-57369-0_1

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  125 in total

Review 1.  Cannabis, Cannabinoids, and Sleep: a Review of the Literature.

Authors:  Kimberly A Babson; James Sottile; Danielle Morabito
Journal:  Curr Psychiatry Rep       Date:  2017-04       Impact factor: 5.285

2.  Cannabinoid-opioid interaction in chronic pain.

Authors:  D I Abrams; P Couey; S B Shade; M E Kelly; N L Benowitz
Journal:  Clin Pharmacol Ther       Date:  2011-11-02       Impact factor: 6.875

3.  Minor oxygenated cannabinoids from high potency Cannabis sativa L.

Authors:  Safwat A Ahmed; Samir A Ross; Desmond Slade; Mohamed M Radwan; Ikhlas A Khan; Mahmoud A ElSohly
Journal:  Phytochemistry       Date:  2015-06-17       Impact factor: 4.072

4.  β-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice.

Authors:  Amine Bahi; Shamma Al Mansouri; Elyazia Al Memari; Mouza Al Ameri; Syed M Nurulain; Shreesh Ojha
Journal:  Physiol Behav       Date:  2014-06-13

5.  Very low doses of delta 8-THC increase food consumption and alter neurotransmitter levels following weight loss.

Authors:  Yosefa Avraham; Dikla Ben-Shushan; Aviva Breuer; Olga Zolotarev; Avital Okon; Nir Fink; Vered Katz; Elliot M Berry
Journal:  Pharmacol Biochem Behav       Date:  2004-04       Impact factor: 3.533

6.  Cannabinoid ester constituents from high-potency Cannabis sativa.

Authors:  Safwat A Ahmed; Samir A Ross; Desmond Slade; Mohamed M Radwan; Fazila Zulfiqar; Rae R Matsumoto; Yan-Tong Xu; Eddy Viard; Robert C Speth; Vardan T Karamyan; M A ElSohly
Journal:  J Nat Prod       Date:  2008-02-28       Impact factor: 4.050

7.  An efficient new cannabinoid antiemetic in pediatric oncology.

Authors:  A Abrahamov; A Abrahamov; R Mechoulam
Journal:  Life Sci       Date:  1995       Impact factor: 5.037

8.  (-)-β-Caryophyllene, a CB2 Receptor-Selective Phytocannabinoid, Suppresses Motor Paralysis and Neuroinflammation in a Murine Model of Multiple Sclerosis.

Authors:  Thaís Barbosa Alberti; Wagner Luiz Ramos Barbosa; José Luiz Fernandes Vieira; Nádia Rezende Barbosa Raposo; Rafael Cypriano Dutra
Journal:  Int J Mol Sci       Date:  2017-04-01       Impact factor: 5.923

9.  Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort.

Authors:  Eric P Baron; Philippe Lucas; Joshua Eades; Olivia Hogue
Journal:  J Headache Pain       Date:  2018-05-24       Impact factor: 7.277

10.  Cannabidivarin (CBDV) suppresses pentylenetetrazole (PTZ)-induced increases in epilepsy-related gene expression.

Authors:  Naoki Amada; Yuki Yamasaki; Claire M Williams; Benjamin J Whalley
Journal:  PeerJ       Date:  2013-11-21       Impact factor: 2.984

View more
  5 in total

Review 1.  The effects of cannabis and cannabinoids on the endocrine system.

Authors:  Farah Meah; Michelle Lundholm; Nicholas Emanuele; Hafsa Amjed; Caroline Poku; Lily Agrawal; Mary Ann Emanuele
Journal:  Rev Endocr Metab Disord       Date:  2021-08-30       Impact factor: 9.306

Review 2.  Modulation of Endocannabinoid System Components in Depression: Pre-Clinical and Clinical Evidence.

Authors:  Uri Bright; Irit Akirav
Journal:  Int J Mol Sci       Date:  2022-05-15       Impact factor: 6.208

Review 3.  Hemp and Its Derivatives as a Universal Industrial Raw Material (with Particular Emphasis on the Polymer Industry)-A Review.

Authors:  Karol Tutek; Anna Masek
Journal:  Materials (Basel)       Date:  2022-03-31       Impact factor: 3.623

4.  Attitudes and Beliefs of Cancer Patients Demanding Medical Cannabis Use in North Thailand.

Authors:  Alongkorn Sukrueangkul; Surachai Phimha; Nitchatorn Panomai; Wongsa Laohasiriwong; Chutikan Sakphisutthikul
Journal:  Asian Pac J Cancer Prev       Date:  2022-04-01

Review 5.  Anti-Microbial Activity of Phytocannabinoids and Endocannabinoids in the Light of Their Physiological and Pathophysiological Roles.

Authors:  Ronit Vogt Sionov; Doron Steinberg
Journal:  Biomedicines       Date:  2022-03-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.